Skip to content

Orange Book Blog

At the intersection of Patent and FDA Law

About
Authors
Disclaimer
Subscribe

Subscribe

Recent Posts

Delaware court says 74% is not “about 80%”
Revisiting Teva v. Lilly
Federal Circuit reiterates a bond is required for preliminary injunctions of generic launches
Hikma v. Amarin: Opinion Analysis
A note on ANDA settlement agreements

Twitter
Facebook
Instagram

Switching to WordPress

September 30, 2025

TypePad has shut down on us, so we’re moving the blog to WordPress. Thank you for your patience as we learn how to navigate this new blog!

Share this:

X
Facebook

Like Loading…

Posted in Uncategorized

Leave a Reply Cancel reply

Comment

Name

Email

Website

Δ

←Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases

Should ANDA filers be using the PTAB to mount early challenges to OB patents?→

Blog at WordPress.com.

Comment
Reblog
Subscribe Subscribed

Orange Book Blog

Have a WordPress.com account? Log in now.
Orange Book Blog
Copy shortlink View post in Reader
Manage subscriptions Sign up Log in
Report this content
Collapse this bar

%d